PUBLIC COMPANY
saveLaekna Inc
updated 2mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 11Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
- phase1A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healthy Overweight/Obese Participants
- phase1Evaluate LAE102 in Healthy and Overweight/Obese Subjects
- phase1A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in Postmenopausal Women
- phase2Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
- phase2A Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer
- phase2Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian
- phase1PhI to Solid Tumors and PhII to Locally Advanced or mTNBC
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that